Taylor Sandison is Chief Medical Officer of Cidara Therapeutics, Inc.. Currently has a direct ownership of 475,845 shares of CDTX, which is worth approximately $5.33 Million. The most recent transaction as insider was on Mar 15, 2024, when has been sold 128,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 476K
30.81% 3M change
25.7% 12M change
Total Value Held $5.33 Million

Taylor Sandison Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 15 2024
BUY
Grant, award, or other acquisition
-
128,750 Added 21.3%
475,845 Common Stock
Mar 11 2024
SELL
Open market or private sale
$13,843 $0.67 p/Share
20,662 Reduced 5.62%
347,095 Common Stock
Sep 11 2023
SELL
Open market or private sale
$17,853 $0.95 p/Share
18,793 Reduced 4.91%
363,757 Common Stock
Mar 27 2023
BUY
Grant, award, or other acquisition
-
90,000 Added 19.21%
378,550 Common Stock
Mar 13 2023
SELL
Open market or private sale
$11,020 $1.53 p/Share
7,203 Reduced 2.44%
288,550 Common Stock
Sep 12 2022
SELL
Open market or private sale
$12,565 $0.68 p/Share
18,478 Reduced 5.96%
291,753 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
-
50,000 Added 14.04%
306,231 Common Stock
Dec 29 2021
BUY
Exercise of conversion of derivative security
-
15,600 Added 5.74%
256,231 Common Stock
Sep 30 2021
BUY
Grant, award, or other acquisition
-
150,600 Added 38.89%
236,631 Common Stock
Mar 31 2021
BUY
Grant, award, or other acquisition
-
700 Added 0.85%
82,031 Common Stock
TS

Taylor Sandison

Chief Medical Officer
San Diego, CA

Track Institutional and Insider Activities on CDTX

Follow Cidara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDTX shares.

Notify only if

Insider Trading

Get notified when an Cidara Therapeutics, Inc. insider buys or sells CDTX shares.

Notify only if

News

Receive news related to Cidara Therapeutics, Inc.

Track Activities on CDTX